Qiaomei Jin

Title: Innovator Qiaomei Jin: Pioneering Medicinal Chemistry with Patent for Pyrazole Kinase Inhibitors

Introduction:

Qiaomei Jin, an accomplished inventor based in Jiangsu, China, has made significant strides in the field of medicinal chemistry. Known for his innovative approaches to drug development, he holds a patent that focuses on inhibitors for protein kinases, which are crucial in cancer treatment.

Latest Patents:

Qiaomei Jin’s notable patent is titled "Polycyclic substituted pyrazole kinase activity inhibitors and use thereof." This invention pertains to 4-(five-membered heterocyclic pyrimidine/pyridine substituted) amino-1H-3-pyrazolecarboxamide derivatives. The patent outlines the preparation method, pharmaceutical compositions, and medicinal applications of these compounds, particularly emphasizing their capability as protein kinase inhibitors for anti-tumor usage.

Career Highlights:

Qiaomei Jin works at Shanghai Fosun Pharmaceutical Development Co., Ltd., a prominent player in the pharmaceutical sector. His contributions to the company have positioned him as a key figure in the development of novel therapeutic solutions. His expertise in medicinal chemistry is evident through his innovative patenting activities and involvement in cutting-edge research.

Collaborations:

Throughout his career, Qiaomei Jin has collaborated with esteemed colleagues such as Tao Lu and Yue Wang. These partnerships exemplify the teamwork often necessary in advancing pharmaceutical research and developing effective medicinal products.

Conclusion:

Qiaomei Jin stands out as an innovative mind in the realm of medicinal chemistry. With his patent on pyrazole kinase activity inhibitors, he has made a substantial contribution to cancer treatment methodologies. His work at Shanghai Fosun Pharmaceutical Development Co., Ltd., alongside reputable collaborators, enhances the potential for breakthroughs in pharmaceutical advancements, underscoring the vital role of inventors in the healthcare industry.